Available over the counter at most drug stores, blood test kits for the adynomine receptor of the Suresh Linkage Complex (a protein found only in Evolved humans) allow quick and reliable testing that is as simple as four easy steps. Primarily produced by the Pharmatech company, these test kits make it possible to determine if an individual is SLC-Expressive.
The test kits work by exposure of blood to chemically reactive, antibody-containing pads included in the kit. A lancet, designed to prick the subject's finger, allows for blood to be dropped or smeared onto four circular pads on a stiff cardboard backing. The redundancy of the four pads reduces the possibility of a false negative from a faulty kit.
Blood applied to these pads will turn the entire circular pad (not just the applied area) blue through chemical reaction if their blood cells do not express proteins from the Suresh Linkage Complex. If the pad turns blue, it means that the SLC is present while red indicates a negative result. If responses vary across the pads, a second test is recommended to ensure an accurate reading.
These test kits are publicly available, at an average cost of $20. Free clinical testing is available at all hospitals, and most police stations are equipped with testing kits for use by law enforcement officers.
Significance
Following the February 2007 revelation of the Evolved by then-New York Senator Nathan Petrelli, the emergence of the Evolved onto the world's stage caused dramatic social and political changes to sweep the world. The instating of the Linderman Act on June 15, 2007 all Evolved Humans in the United States were required to come forward and register with the government in a national registry.
However, it was not until the winter of 2008 that scientists were able to isolate a protein distinct to Evolved (now called the adynomine receptor) and devise an antibody that could be used to test for its presence. The test kits that emerged in that chaotic time allowed the government to recognize and actively enumerate the Evolved population of the country in an efficient and expedient manner. However, the original test kits released in 2008 and early 2009 were rushed to production by Pharmatech and were prone to producing false negatives. In the years since, added redundancy has improved the test's accuracy, although — as with all diagnostic tests — there remains a statistically small margin of error for false negatives.
Speculation in the media persists that the first "faulty" batches of test kits may have been intentional sabotage by pro-Evolved groups in an attempt to undermine the Linderman Act, though no proof has ever been raised for these allegations.
 |
|---|
Currently in the keeping of:
Publicly Available